RBR-6gdmb8c进行中（未招募）不适用
Technological platforms for the diagnosis and control of COVID-19.
Imunoscan Engenharia Molecular LTDA0 个研究点开始时间: 2021年5月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Health professionals; emergency care patients; patients admitted to the infirmary; intensive care unit patients; symptomatic or asymptomatic for COVID-19.
排除标准
- •Volunteers without contact with COVID-19 virus.
研究者
相似试验
招募中
不适用
Development of diagnostic and therapeutic support tools for scoliosis using deep learningScoliosisJPRN-UMIN000048005niversity of Toyama200
招募中
不适用
Development of Digital Diagnostics & Therapeutics for DementiaMental and behavioural disordersKCT0007545Jeonbuk National University200
尚未招募
不适用
Development of simple support tool for the diagnosis of frontotemporal lobar degeneration by speech analysis using artificial intelligenceFTLD ALS ADJPRN-UMIN000033763agoya University Department of Neurology120
招募中
不适用
Development of diagnostic technology for neurological disorders using a patch-type electroencephalographneuropsychiatric disordersJPRN-UMIN000042903Osaka University200
尚未招募
Unknown
DEVELOPMENT OF AMA ASSESSMENT TOOL AND KNOW THE EFFECT OF AMA ON PRO-INFLAMATORY MARKERCTRI/2023/09/057837KLE Academy of Higher education and research belagavi karnataka